Loading blog post…
A complete guide to allantoin in skincare — cell proliferation and wound healing mechanisms, keratolytic activity, clinical evidence, why it's in almost every gentle moisturizer, and what concentrations actually work.
· By MedSpot Editorial · 5 min read
Allantoin appears as an ingredient in an enormous range of skincare products — from baby creams to post-laser recovery serums — yet it rarely gets its own feature. That's partly because it works quietly and reliably without drama. Here's what it actually does and why it's so ubiquitous.
Allantoin is a diureide of glyoxylic acid — a naturally occurring compound found in comfrey root (Symphytum officinale), sugar beets, wheat sprouts, and the urine of most mammals. It's also a byproduct of uric acid oxidation.
Modern cosmetic allantoin is synthetically produced (from uric acid or glyoxylic acid) for purity and supply consistency — the same molecule as the naturally occurring form but not plant-extracted.
Regulatory status: Allantoin is an FDA-approved OTC skin protectant (Category I, skin protectant monograph) at concentrations of 0.5–2%. One of a small number of skincare ingredients with an OTC drug approval.
Allantoin's most important mechanism is stimulating keratinocyte and fibroblast proliferation — triggering cell division in the skin's key cell types:
Hansson et al. (1992, Wound Repair and Regeneration) — established allantoin's cell proliferative effect in wound models. The mechanism involves interaction with cellular growth factor receptors and modulation of the cell cycle.
This mechanism makes allantoin especially valuable for:
At concentrations above 0.2%, allantoin has keratolytic properties — it loosens corneocyte cohesion, facilitating shedding of dead skin cells. This is much milder than AHA/BHA exfoliation:
The keratolytic effect is the reason allantoin appears in products targeting rough skin, calluses, keratosis pilaris, and post-peel regeneration — it gently removes dead cell buildup while simultaneously stimulating fresh cell production below.
Allantoin reduces skin irritation through:
This anti-irritant property is why allantoin appears in aftershaves, post-depilatory creams, and products designed for compromised skin — it directly reduces the stinging and burning sensation from mechanical or chemical skin disruption.
Allantoin attracts water to the stratum corneum — a modest humectant effect that complements its cell-proliferative and soothing properties.
Wound healing studies consistently demonstrate allantoin's benefit:
Pommier et al. (2004, Journal of Clinical Oncology) — a large RCT (n=254) comparing allantoin-containing cream (Biafine) vs. emollient alone for radiation dermatitis found significant reduction in skin toxicity in the allantoin arm. This is one of the largest controlled trials specifically for a topical allantoin formulation.
Multiple smaller studies in the dermatology and wound care literature confirm accelerated wound closure and reduced inflammation with allantoin-containing preparations.
Multiple controlled studies confirm allantoin-containing moisturizers reduce TEWL and improve skin hydration in xerosis patients. The cell proliferation mechanism supports a more functional barrier rather than just coating the surface.
Allantoin is standard in post-laser, post-peel, and post-microneedling recovery products. The wound-healing and cell proliferation mechanisms are directly relevant to these use cases, and the anti-irritant property addresses the immediate discomfort of treated skin.
Allantoin has a combination of properties that make it nearly universally valuable as a formulation ingredient:
No significant irritation potential, no photosensitivity, no contraindications. This explains its presence in everything from baby wash to medical-grade wound care.
| Concentration | Effect |
|---|---|
| 0.1–0.2% | Soothing, anti-irritant (below keratolytic threshold) |
| 0.2–0.5% | Mild keratolytic + soothing; standard cosmetic range |
| 0.5–2% | FDA OTC skin protectant range; keratolytic + cell proliferative |
| Above 2% | No additional benefit demonstrated; not standard |
Most effective moisturizers and wound-care products use 0.5–2%. Products listing allantoin in the second half of the ingredient list likely contain it at cosmetic (sub-0.5%) concentrations primarily for its soothing and anti-irritant properties.
| Ingredient | Cell proliferation | Keratolytic | Anti-inflammatory | Humectant | FDA OTC |
|---|---|---|---|---|---|
| Allantoin | Yes | Mild | Yes | Mild | Yes (skin protectant) |
| Panthenol (B5) | Yes | No | Yes | Mild | No |
| Centella asiatica | Yes (collagen synthesis) | No | Yes (NF-κB) | No | No |
| Colloidal oatmeal | No | No | Yes (avenanthramides) | No | Yes (skin protectant) |
| Zinc oxide | No | No | Yes | No | Yes (skin protectant) |
Allantoin and panthenol are highly complementary — both stimulate keratinocyte proliferation through different pathways, both are anti-inflammatory, and they appear together in many of the most effective post-procedure recovery formulations.
Daily moisturizer: Allantoin is a passive ingredient in many moisturizers — use as directed. For dry, irritated, or compromised skin, look for formulations listing allantoin in the top 5–8 ingredients (indicating 0.5%+).
Post-procedure recovery: Apply allantoin-containing cream 1–3 days after laser, microneedling, or peel once the immediate healing phase allows topical application. Continue for 1–2 weeks.
Keratosis pilaris (KP): Products combining allantoin (keratolytic + cell proliferative) with lactic acid (AHA exfoliation) or urea (keratolytic) address the follicular keratin plugging of KP effectively. Apply to damp skin after showering.
No timing restrictions: AM, PM, both — no photosensitivity, no interaction concerns.
Looking for a skincare consultation? Browse skincare providers on MedSpot →